Racing Victoria has dragged fantasy sports gambling company PlayUp to court for allegedly infringing its ‘Best Bets’ trade marks.
Australia’s largest intellectual property services firm IPH will maintain its dominance after winning a takeover battle for Xenith IP, a deal that will create a formidable IP services giant with over 1,000 employees across Asia Pacific.
A judge has denied Mylan’s bid to temporarily block Sun Pharma and Cipla from making generic versions of anti-cholesterol drug Lipidil while it appeals a ruling invalidating several claims of its patents for the drug, citing the “difficulty, complexity and uncertainty” in assessing compensation under an undertaking as to damages in pharmaceutical patent proceedings.
E-retail giant Catch Group has settled a lawsuit against Kogan for alleging violating its “catch” trade marks and the consumer law through sponsored links on Google driven by phrases using the word “catch”.
IP services company QANTM has signaled the end to a bidding war to acquire rival Xenith IP, saying it will not match the terms of the latest offer lodged by fellow IP services provider IPH that would see it acquire Xenith outright.
US lingerie company Victoria’s Secret has reached a settlement in a lawsuit over the sale of knockoff products that mimic the get-up of its trade marked body care products.
F. Hoffman La-Roche has reached a settlement in a patent lawsuit over Sandoz’s plan to market a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
The takeover battle for Xenith IP has entered round two, with IPH submitting a revised proposal to acquire the IP services firm in full, leaving fellow suitor QANTM with three days to lodge a competing offer.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
A case simultaneously challenging IP Australia’s decisions to accept, grant and certify an innovation patent owned by one of Australia’s biggest building product companies has been withdrawn, a court has heard.